Cigna Investments’s SLB Ltd SLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $665K | Buy |
14,285
+93
| +0.7% | +$4.98K | 0.09% | 200 |
|
|
2026
Q1 | $729K | Hold |
14,192
| – | – | 0.11% | 167 |
|
|
2025
Q4 | $545K | Sell |
14,192
-276
| -2% | -$10K | 0.08% | 217 |
|
|
2025
Q3 | $497K | Buy |
14,468
+1,124
| +8% | +$39.1K | 0.07% | 241 |
|
|
2025
Q2 | $451K | Sell |
13,344
-726
| -5% | -$25.2K | 0.08% | 243 |
|
|
2025
Q1 | $588K | Sell |
14,070
-612
| -4% | -$25.1K | 0.11% | 189 |
|
|
2024
Q4 | $563K | Hold |
14,682
| – | – | 0.1% | 200 |
|
|
2024
Q3 | $616K | Sell |
14,682
-330
| -2% | -$14.7K | 0.11% | 184 |
|
|
2024
Q2 | $708K | Sell |
15,012
-93
| -0.6% | -$4.49K | 0.13% | 152 |
|
|
2024
Q1 | $828K | Sell |
15,105
-124
| -0.8% | -$6.25K | 0.16% | 132 |
|
|
2023
Q4 | $793K | Sell |
15,229
-111
| -0.7% | -$6.03K | 0.16% | 128 |
|
|
2023
Q3 | $894K | Sell |
15,340
-1,886
| -11% | -$109K | 0.2% | 108 |
|
|
2023
Q2 | $847K | Buy |
17,226
+92
| +0.5% | +$4.39K | 0.16% | 129 |
|
|
2023
Q1 | $841K | Sell |
17,134
-289
| -2% | -$15.3K | 0.17% | 123 |
|
|
2022
Q4 | $932K | Buy |
17,423
+28
| +0.2% | +$1.39K | 0.19% | 116 |
|
|
2022
Q3 | $624K | Sell |
17,395
-829
| -5% | -$30.1K | 0.14% | 154 |
|
|
2022
Q2 | $652K | Sell |
18,224
-6,524
| -26% | -$272K | 0.13% | 162 |
|
|
2022
Q1 | $1.02M | Sell |
24,748
-6,991
| -22% | -$274K | 0.13% | 158 |
|
|
2021
Q4 | $950K | Sell |
31,739
-10,900
| -26% | -$343K | 0.07% | 218 |
|
|
2021
Q3 | $1.26M | Sell |
42,639
-1,070
| -2% | -$30.7K | 0.09% | 188 |
|
|
2021
Q2 | $1.4M | Sell |
43,709
-6,538
| -13% | -$201K | 0.1% | 172 |
|
|
2021
Q1 | $1.37M | Buy |
50,247
+1,765
| +4% | +$46.5K | 0.09% | 196 |
|
|
2020
Q4 | $1.06M | Buy |
48,482
+3,882
| +9% | +$73.3K | 0.08% | 228 |
|
|
2020
Q3 | $694K | Buy |
44,600
+350
| +0.8% | +$6.51K | 0.07% | 268 |
|
|
2020
Q2 | $814K | Buy |
44,250
+5,328
| +14% | +$93.3K | 0.08% | 245 |
|
|
2020
Q1 | $525K | Buy |
38,922
+2,350
| +6% | +$68K | 0.07% | 312 |
|
|
2019
Q4 | $1.23M | Sell |
36,572
-3,727
| -9% | -$133K | 0.13% | 205 |
|
|
2019
Q3 | $1.32M | Buy |
40,299
+1,720
| +4% | +$62.9K | 0.14% | 190 |
|
|
2019
Q2 | $1.54M | Sell |
38,579
-1,300
| -3% | -$52.4K | 0.17% | 142 |
|
|
2019
Q1 | $1.74M | Sell |
39,879
-320
| -0.8% | -$13.8K | 0.19% | 107 |
|
|
2018
Q4 | $1.45M | Buy |
40,199
+165
| +0.4% | +$8.14K | 0.12% | 117 |
|
|
2018
Q3 | $2.05M | Sell |
40,034
-3,922
| -9% | -$253K | 0.16% | 88 |
|
|
2018
Q2 | $2.95M | Sell |
43,956
-6,635
| -13% | -$456K | 0.21% | 67 |
|
|
2018
Q1 | $3.28M | Sell |
50,591
-668
| -1% | -$46.7K | 0.22% | 63 |
|
|
2017
Q4 | $3.46M | Sell |
51,259
-1,463
| -3% | -$94.8K | 0.23% | 61 |
|
|
2017
Q3 | $3.68M | Sell |
52,722
-1,050
| -2% | -$69.4K | 0.25% | 55 |
|
|
2017
Q2 | $3.57M | Sell |
53,772
-3,564
| -6% | -$255K | 0.25% | 54 |
|
|
2017
Q1 | $4.51M | Buy |
57,336
+5,959
| +12% | +$487K | 0.31% | 42 |
|
|
2016
Q4 | $4.31M | Buy |
+51,377
| New | +$4.21M | 0.47% | 38 |
|
Other funds holding SLB
Cigna Investments's SLB Position: Q2 2026 in Review
Cigna Investments increased its SLB Ltd (SLB) stake by 0.66% in Q2 2026, buying an estimated $4.98K and bringing the position to 14,285 shares worth $665K. The position accounts for 0.09% of the portfolio, ranked #200.
Cigna Investments first reported a position in SLB in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.51M in Q1 2017. 1,692 funds tracked by Wall St. Rank hold SLB as of Q2 2026.
- Cigna Investments held 14,285 shares of SLB Ltd worth $665K as of Q2 2026.
- Cigna Investments bought 93 SLB Ltd shares in Q2 2026, an estimated $4.98K.
- SLB Ltd made up 0.09% of Cigna Investments's portfolio in Q2 2026, its #200 holding.
- Cigna Investments first reported a position in SLB Ltd in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's SLB Ltd position peaked at $4.51M in Q1 2017.
- 1,692 funds tracked by Wall St. Rank held SLB Ltd as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.